focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 22.20
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 3.80 (17.117%)
Open: 24.50
High: 0.00
Low: 0.00
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: SkinBio launches food supplement on Amazon

Thu, 30th Nov 2023 14:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Iofina PLC - Colorado, US-based manufacturing company that specialises in the production of iodine and the manufacture of speciality chemical derivatives - Reminds investors that the ramp-up of IO9, its iodine plant in Western Oklahoma, took longer than expected. Says that recent upgrades have improved the flow of brine water to the plant, adding that it has been able to steadily increase crystalline iodine production following the completion of this work. Confirms that the plant is now operating within its expected output range. Expects second-half production at the bottom, or very marginally below, the bottom end of the forecast range of 325 to 350 metric tonnes.

----------

SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Says that its AxisBiotix-Ps food supplement will launch on Amazon.co.uk from December 6. AxisBiotix-Ps is designed to help alleviate sensitive skin conditions like psoriasis. SkinBio Therapeutics says the sale of the product on Amazon is a key part of its commercialisation strategy, and that it aims to extend product availability through other Amazon country sites. Says management is already proactively seeking to expand online sales of AxisBiotix-Ps into France, Italy, and Spain, where the product has regulatory clearance.

----------

Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Notes strategic progress towards end of first quarter, including contracts signed for four new projects, with additional contracts approved by customers and due to be signed in the second quarter. Says three of the contracts are with major pharmaceutical companies who were existing customers, while the fourth is with a new customer focused on "high throughput drug discovery". Chief Executive Officer Martin Gouldstone says: "I am encouraged to see the commercial traction already being made on delivering our strategy, including our ability to expand the application of our ImmunoINSIGHTS platform into drug discovery as well as clinical trials. I have recently spent time discussing our strategy with some of our key stakeholders and have been pleased to see how well it has been received, also allowing us to recruit top talent to further accelerate our ability to deliver on it."

----------

Baron Oil PLC - London-based oil & gas exploration and appraisal company - Celebrates as its wholly-owned owned subsidiary, SundaGas Banda Unipessoal Lda, gets project classification from Autoridade Nacional do Petroleo for the Chuditch field. Sundagas is the operator of the TL-SO-19-16 production sharing contract, offshore Timor-Leste, while ANP is the Timor-Leste government regulator for oil and gas. The next step is the submission of a term of reference, including initial public consultations. Baron Oil adds that, regarding drilling, a Timorese drilling engineer has been recruited to join the SundaGas well operations team, and expressions of interest are being sought from in-country suppliers to provide services from the Timorese private sector. It also continues to evaluate all potential options for gas export from the Chuditch field in order to be able to fast track the concept selection processes.

----------

Arkle Resources PLC - Exploration company, with principal assets in Irish gold and zinc exploration licences - Says a drilling programme at Inishowen in County Donegal is due to begin this week. The drilling, which is a follow-up to work at the Meeneragh target, will test the main gold bearing outcrop. Four holes are planned in this phase from two drill pads drilling at minus 45 and minus 70 degrees. The focus of the programme will be on the main vein target discovered earlier. Chair John Teeling says: "It is good to get back on the ground again at Inishowen. This new round of drilling will test to see if we can trace the main vein along strike and at depth. We found high grade gold in the area and we now aim to expand this."

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Feb 2023 09:36

CORRECT: Oncimmune works with Siemens Healthineers on cancer therapy

(Correcting headquarters location of Siemens Healthineers.)

Read more
17 Feb 2023 15:53

Oncimmune enters collaboration with Siemens Healthineers

(Sharecast News) - Immunodiagnostics specialist Oncimmune announced a collaboration with Siemens Healthineers on Friday, to improve malignancy risk assessment of indeterminate pulmonary nodules (IPNs).

Read more
17 Feb 2023 10:30

AIM WINNERS & LOSERS: Purplebricks drops as turnaround plan continues

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
17 Feb 2023 10:10

Oncimmune partners with Siemens Healthineers on lung cancer therapy

(Alliance News) - Oncimmune Holdings PLC on Friday said that it has collaborated with Siemens Healthineers AG, a Frankfurt-based medical technology company, in order to improve malignancy risk assessment in lung cancer.

Read more
9 Dec 2022 19:51

TRADING UPDATES: FBD loses CFO; Eqtec wins GBP 2 million loan facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
23 Sep 2022 15:56

UK earnings, trading statements calendar - next 7 days

Monday 26 September 
Atome Energy PLCHalf Year Results
Chapel Down Group PLCHalf Year Results
Concurrent Technologies PLCHalf Year Results
CPPGroup PLCHalf Year Results
Devolver Digital IncHalf Year Results
Dillistone Group PLCHalf Year Results
Finsbury Food Group PLCFull Year Results
Frenkel Topping Group PLCHalf Year Results
Immotion Group PLCHalf Year Results
Likewise Group PLCHalf Year Results
Microlise Group PLCHalf Year Results
Next Fifteen Communications PLCHalf Year Results
SpaceandPeople PLCHalf Year Results
XLMedia PLCHalf Year Results
Xpediator PLCHalf Year Results
Tuesday 27 September 
AG Barr PLCHalf Year Results
Animalcare Group PLCHalf Year Results
Billington Holdings PLCHalf Year Results
Boku IncHalf Year Results
Card Factory PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Diaceutics PLCHalf Year Results
Digitalbox PLCHalf Year Results
ECSC Group PLCHalf Year Results
Ergomed PLCHalf Year Results
Ferguson PLCFull Year Results
FireAngel Safety Technology Group PLCHalf Year Results
GENinCode PLCHalf Year Results
Gresham House Energy Storage Fund PLCHalf Year Results
K3 Capital Group PLCFull Year Results
Instem PLCHalf Year Results
LifeSafe Holdings PLCHalf Year Results
Medica Group PLCHalf Year Results
Mission Group PLCHalf Year Results
Mortgage Advice Bureau PLCHalf Year Results
NAHL Group  PLCHalf Year Results
Origin Enterprises PLCFull Year Results
United Utilities Group PLCTrading Statement
Personal Group Holdings PLCHalf Year Results
S&U PLCHalf Year Results
Saga PLCHalf Year Results
Serica Energy PLCHalf Year Results
SSP Group PLCTrading Statement
tinyBuild IncHalf Year Results
Transense Technologies PLCFull Year Results
Yu Group PLCHalf Year Results
Wednesday 28 September 
1Spatial PLCHalf Year Results
AVI Japan Opportunity Trust PLCHalf Year Results
Avingtrans PLCFull Year Results
Blancco Technology Group PLCFull Year Results
boohoo Group PLCHalf Year Results
DP Poland PLCHalf Year Results
Everyman Media Group PLCHalf Year Results
Octopus Renewables Infrastructure Trust PLCHalf Year Results
Shepherd Neame LtdFull Year Results
Skillcast Group PLCHalf Year Results
SolGold PLCFull Year Results
Thursday 29 September 
Allergy Therapeutics PLCFull Year Results
Angle PLCHalf Year Results
Avation PLCFull Year Results
Bango PLCHalf Year Results
Cap-XX LtdHalf Year Results
Celadon Pharmaceuticals PLCHalf Year Results
Crestchic PLCHalf Year Results
Directa Plus PLCTrading Statement
McBride PLCFull Year Results
NAHL Group PLCHalf Year Results
Next PLCHalf Year Results
Novacyt SAHalf Year Results
Physiomics PLCFull Year Results
Synairgen PLCHalf Year Results
XLMedia PLCHalf Year Results
Friday 30 September 
abrdn Property Income Trust LtdHalf Year Results
Bluefield Solar Income Fund LtdFull Year Results
Cineworld Group PLCHalf Year Results
CMO Group PLCHalf Year Results
Dignity PLCHalf Year Results
DP Eurasia NVHalf Year Results
DX Group PLCFull Year Results
Glantus Holdings PLCHalf Year Results
HealthBeacon PLCHalf Year Results
ImmuPharma PLCHalf Year Results
Iofina PLCHalf Year Results
Oncimmune Holdings PLCHalf Year Results
Pennon Group PLCTrading Statement
Quarto Group IncHalf Year Results
Strip Tinning Holdings PLCHalf Year Results
Trellus Health PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Sep 2022 15:08

Oncimmune shares plummet as company reports widened pretax loss

(Alliance News) - Oncimmune Holdings PLC on Wednesday reported a substantial widening in its pretax loss as administrative expenses increased in its end of year report.

Read more
21 Sep 2022 10:29

AIM WINNERS & LOSERS: City Pub rises on profit swing; LBG Media falls

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
8 Jul 2022 11:42

IN BRIEF: Oncimmune shares dip as Chair Meinhard Schmidt departs

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - Appoints Alistair MacDonald as new chair as now ex-chair Meinhard Schmidt retires from the board. Firm adds it has a pipeline of potential contracts. "I am delighted to be handing over the reins to Alistair with his wealth of experience in growing pharma services business," says Schmidt.

Read more
8 Apr 2022 15:44

Oncimmune agrees two new commercial contracts

(Sharecast News) - Immunodiagnostics company Oncimmune announced the signing of two new commercial contracts for its 'ImmunoINSIGHTS' platform on Friday.

Read more
8 Apr 2022 10:54

IN BRIEF: Oncimmune shares lifted on two new US contract wins

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - Signs two further ImmunoInsights commercial contracts. One contract is with an unnamed US-based clinical-stage biopharmaceutical company, that develops cellular immunotherapies for cancer patients. Oncimmune will provide the customer with its biomarker discover platform SeroTag to identify autoantibodies. Second contract is with another US clinical-stage biopharmaceutical company which is developing immune system-related technologies.

Read more
7 Mar 2022 21:38

IN BRIEF: Oncimmune signs follow-on Covid autoimmunity contract

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - Signs follow-on contract with unnamed US research organisation to validate findings from prior study to assess the autoimmune response to Covid-19 infection.

Read more
4 Mar 2022 20:53

TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

Read more
28 Feb 2022 19:41

TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
28 Feb 2022 14:41

Oncimmune signs new contract with Alphabet division Verily

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the signing of a new commercial contract with Verily Life Sciences on Monday, a member of Google owner Alphabet's stable, focusing on the autoantibody profiling of patients who had Covid-19 and gone on to develop long lasting symptoms for more than four weeks, or 'long Covid'.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.